CYP2S1: a short review.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2005-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.TAAP.2004.12.027PMID 16054184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel extrahepatic cytochrome P450s.

  2005cited by this paper
• Regulation of the Cyp2a5 Gene Involves an Aryl Hydrocarbon Receptor-Dependent Pathway

  2005cited by this paper
• HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE

  2005cited by this paper
• Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis

  2005cited by this paper
• Localization of Cytochrome P450 CYP2S1 Expression in Human Tissues by In Situ Hybridization and Immunohistochemistry

  2005cited by this paper
• Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues.

  2005cited by this paper
• Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1

  2004cited by this paper
• 57 varieties: the human cytochromes P450.

  2004cited by this paper
• Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population.

  2004cited by this paper
• Expression of cytochrome P450 in tumor tissues and its association with cancer development.

  2004cited by this paper
• Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

  2004cited by this paper
• Establishment of a rapid TaqMan((R))-assay for genotyping polymorphic alleles of cytochrome P450 enzymes in human tissue

  2004cited by this paper
• Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

  2004cited by this paper
• Epidermal CYP2 family cytochromes P450.

  2004cited by this paper
• Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR.

  2003cited by this paper
• Retinoic acid metabolism and mechanism of action: a review.

  2003cited by this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cited by this paper
• Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases.

  2003cited by this paper
• Identification of Novel Roles of the Cytochrome P450 System in Early Embryogenesis: Effects on Vasculogenesis and Retinoic Acid Homeostasis

  2003cited by this paper
• Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues.

  2003cited by this paper
• Naphthalene—an environmental and occupational toxicant

  2003cited by this paper
• Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes.

  2003cited by this paper
• Catalog of 680 variations among eight cytochrome P450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population

  2003cited by this paper
• Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung

  2002cited by this paper
• Clinical importance of the cytochromes P450.

  2002cited by this paper
• Identification of a novel dioxin-inducible cytochrome P450.

  2002cited by this paper
• Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19.

  2001cited by this paper
• Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1).

  2001cited by this paper
• Roles of Cytochrome P450 in Development

  2001cited by this paper
• Cytochrome P450s: coupling development and environment.

  2001cited by this paper
• Polymorphisms of CYP2A6 and its practical consequences.

  2001cited by this paper
• Identification of a 43-kDa protein in human liver cytosol that binds to the 3'-untranslated region of CYP2A6 mRNA.

  2001cited by this paper
• Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.

  2001cited by this paper
• In Situ Hybridization and Immunohistochemical Analysis of Cytochrome P450 1B1 Expression in Human Normal Tissues

  2001cited by this paper
• Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1.

  2000cited by this paper
• The role of cytochrome P450 in tumour development and progression and its potential in therapy

  2000cited by this paper
• Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.

  2000cited by this paper
• Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

  2000cited by this paper
• Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes.

  2000cited by this paper
• A novel positive regulatory element that enhances hamster CYP2A8 gene expression mediated by xenobiotic responsive element.

  1999cited by this paper
• Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells.

  1999cited by this paper
• UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan.

  1999cited by this paper
• Analysis of RNA-protein interactions of mouse liver cytochrome P4502A5 mRNA.

  1999cited by this paper
• Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization.

  1999cited by this paper
• Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.

  1999cited by this paper
• Localization of CYP1A1 mRNA in human lung by in situ hybridization: Comparison with immunohistochemical findings

  1998cited by this paper
• cDNA Cloning of Human Retinoic Acid-metabolizing Enzyme (hP450RAI) Identifies a Novel Family of Cytochromes P450 (CYP26)*

  1997cited by this paper
• Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

  1997cited by this paper
• Cytochrome P450 isoenzyme activities in cultured rat and mouse liver slices.

  1997cited by this paper
• Detection of mRNA encoding xenobiotic‐metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes

  1997cited by this paper
• Metabolic activation of toxins: tissue-specific expression and metabolism in target organs.

  1997cited by this paper
• Ah receptor signaling pathways.

  1996cited by this paper
• The aryl hydrocarbon receptor complex.

  1995cited by this paper
• Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.

  1995cited by this paper
• The AH-receptor: genetics, structure and function.

  1993cited by this paper
• Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions.

  1991cited by this paper
• Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm.

  1990cited by this paper
• Rat testosterone 7 alpha-hydroxylase. Isolation, sequence, and expression of cDNA and its developmental regulation and induction by 3-methylcholanthrene.

  1987cited by this paper

• How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a literature review.

  2026cites this paper
• Upregulation of Genetic Markers of Poor Prognosis following Chemotherapy in Acute Myeloid Leukemia Cells

  2026cites this paper
• Orphan Cytochromes P450 as Possible Pharmacological Targets or Biomarkers in Breast Cancer

  2025cites this paper
• Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDAC

  2025cites this paper
• CYP2S1 Knockout Promotes Intestinal Tumor Growth in APCMin/+ Mice and Its Clinical Significance

  2025cites this paper
• Comparison of the behavior of human lung epithelial cell lines cultured at the air-liquid interface and assessment of their responses after benzo(a)pyrene exposure.

  2025cites this paper
• Bioactive lipids are altered in the heart, kidney, and serum of male and female F344 rats sub-chronically exposed to dietary 2-MCPD.

  2024cites this paper
• A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment

  2024cites this paper
• Key genes of inflammation and Crohn’s disease severity identified via bioinformatics and clinical specimen analysis

  2023cites this paper
• Bisphenol A is a carcinogen that induces lipid accumulation, peroxisome proliferator‑activated receptor‑γ expression and liver disease

  2022cites this paper
• Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy

  2022cites this paper
• CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer

  2022cites this paper
• Comparative Studies on a Standardized Subfraction of Red Onion Peel Ethanolic Extract (Plant Substance), Quercetin (Pure Compound), and Their Cell Mechanism and Metabolism on MDA-MB-231

  2022influential citation
• Oral enzymatic detoxification system: Insights obtained from proteome analysis to understand its potential impact on aroma metabolization.

  2021cites this paper
• Quercetin and a plant substance, identified using a multi-copy number of DNA topoisomerase I in recombinant Pichia pastoris, inhibited MDA-MB-231 proliferation via different manners.

  2021cites this paper
• Knockdown CYP2S1 inhibits lung cancer cells proliferation and migration

  2021cites this paper
• Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update

  2021cites this paper
• Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies

  2021cites this paper
• Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification

  2021cites this paper
• Circular RNA circ_0023404 serves as a miR‐636 sponge to promote malignant behaviors in cervical cancer cells through upregulation of CYP2S1

  2021cites this paper
• Arsenic: Various species with different effects on cytochrome P450 regulation in humans

  2021cites this paper
• CYP2S1 is a synthetic lethal target in BRAFV600E-driven thyroid cancers

  2020cites this paper
• The Cellular and Molecular Determinants of Naphthoquinone-Dependent Activation of the Aryl Hydrocarbon Receptor

  2020cites this paper
• Cytochrome P450

  2020cites this paper
• The molecular mechanism of AhR-ARNT-XREs signaling pathway in the detoxification response induced by polycyclic aromatic hydrocarbons (PAHs) in clam Ruditapes philippinarum.

  2020cites this paper
• Inhibition and induction of CYP enzymes in humans: an update

  2020cites this paper
• Study on the AhR signaling pathway and phase II detoxification metabolic enzymes isoforms in scallop Chlamys farreri exposed to single and mixtures of PAHs.

  2020cites this paper
• A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid ω-1 Hydroxylation Using an Untargeted Metabolomic Approach

  2019influential citation
• Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes

  2019cites this paper
• In vitro recombinant yeast assay reveals the binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and aryl hydrocarbon receptor (AhR) from scallop Chlamys farreri.

  2019cites this paper
• In vitro toxicological evaluation of emissions from catalytic oxidation removal of industrial VOCs by air/liquid interface (ALI) exposure system in repeated mode.

  2019cites this paper
• 15.12 – Selected Pneumotoxic Agents☆

  2018cites this paper
• Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models

  2018cites this paper
• The detoxification responses, damage effects and bioaccumulation in the scallop Chlamys farreri exposed to single and mixtures of benzo[a]pyrene and chrysene.

  2017cites this paper
• Loss of PHD3 in myeloid cells dampens the inflammatory response and fibrosis after hind-limb ischemia

  2017cites this paper
• Chapter 1 Introduction EG van de Kerkhof IAM de Graaf GMM Groothuis

  2017cites this paper
• Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines

  2016cites this paper
• Colon Cancer Specific Cytochrome P 450 2 W 1 : Polymorphism , Membrane Topology and Endogenous Roles in Development

  2016cites this paper
• The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.

  2016cites this paper
• Identification of by-products issued from the catalytic oxidation of toluene by chemical and biological methods

  2015cites this paper
• Preparation and application of anti-peptide antibodies for detection of orphan cytochromes P450.

  2015cites this paper
• The Anticancer Drug Ellipticine Activated with Cytochrome

  2015cites this paper
• Bioaccumulation and detoxification responses in the scallop Chlamys farreri exposed to tetrabromobisphenol A (TBBPA).

  2015cites this paper
• Hypothesis-based weight-of-evidence evaluation and risk assessment for naphthalene carcinogenesis

  2015cites this paper
• Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models

  2014cites this paper
• TCDD dysregulation of 13 AHR-target genes in rat liver.

  2014cites this paper
• The Pharmacology of the Cytochrome P 450 Epoxygenase / Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease

  2014influential citation
• PHARMREV007781 1106..1140

  2014influential citation
• The Pharmacology of the Cytochrome P450 Epoxygenase/Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease

  2014cites this paper
• The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes

  2014cites this paper
• Extrahepatic metabolism at the body's internal–external interfaces

  2014cites this paper
• Nowe cytochromy P 450 jako biomarkery i potencjalne cele oddziaływania w chemioprewencji i terapii nowotworów New cytochrome P 450 isoforms as cancer biomarkers and targets for chemopreventive and chemotherapeutic agents

  2013cites this paper
• The effect of benzo[a]pyrene on metabolic activation of anticancer drug ellipticine in mice.

  2013cites this paper
• Functional polymorphism of CYP2B6 G15631T is associated with hematologic and cytogenetic response in chronic myeloid leukemia patients treated with imatinib

  2013cites this paper
• Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.

  2013cites this paper
• New cytochrome P450 1B1, 1C1, 2Aa, 2Y3, and 2K genes from Chinese rare minnow (Gobiocypris rarus): Molecular characterization, basal expression and response of rare minnow CYP1s and CYP2s mRNA exposed to the AHR agonist benzo[a]pyrene.

  2013cites this paper
• Genetic determinants of metabolic syndrome in Lyon Hypertensive rats

  2013cites this paper
• Modulation of Aryl Hydrocarbon Receptor Regulated-Genes by Mercury

  2013cites this paper
• Ontogenesis of phase I hepatic drug metabolic enzymes in sheep.

  2012cites this paper
• Identifying Aryl Hydrocarbon Receptor Modulators from a Natural Source

  2012cites this paper
• Induction of cytochrome P450 enzymes: a view on human in vivo findings

  2012cites this paper
• p-Anilinoaniline Enhancement of Dioxin-Induced CYP1A1 Transcription and Aryl Hydrocarbon Receptor Occupancy of CYP1A1 Promoter: Role of the Cell Cycle

  2012cites this paper
• Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques

  2012cites this paper
• p -Anilinoaniline Enhancement of Dioxin-induced CYP1A1 Transcription and Aryl Hydrocarbon Receptor Occupancy of CYP1A1 Promoter: Role of the Cell Cycle

  2012cites this paper
• Cytochrome P450 2S1 Depletion Enhances Cell Proliferation and Migration in Bronchial Epithelial Cells, in Part, through Modulation of Prostaglandin E2 Synthesis

  2012cites this paper
• Changes in Expression of Drug-Metabolizing Enzymes by Single-Walled Carbon Nanotubes in Human Respiratory Tract Cells

  2012cites this paper
• RUNNING TITLE PAGE CYP2S1 depletion promotes cell proliferation and migration

  2012cites this paper
• Later-life Effects of Mitochondrial DNA Damage During Development in the Whole Organism Model Caenorhabditis elegans

  2012cites this paper
• How functional foods play critical roles in human health

  2012cites this paper
• Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology

  2011cites this paper
• CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

  2011influential citation
• Preclinical Development CYP 2 S 1 and CYP 2 W 1 Mediate 2-( 3 , 4-Dimethoxyphenyl )-5-Fluorobenzothiazole ( GW-610 , NSC 721648 ) Sensitivity in Breast and Colorectal Cancer Cells

  2011influential citation
• Species difference in the regulation of cytochrome P450 2S1: lack of induction in rats by the aryl hydrocarbon receptor agonist PCB126

  2011cites this paper
• Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency.

  2011cites this paper
• Cytochromes P450 are essential players in the vitamin D signaling system.

  2011cites this paper
• External influences on the immune system via activation of the aryl hydrocarbon receptor.

  2011influential citation
• Mechanisitic studies of the toxicities of the aryl hydrocarbon receptor agonist PCB126

  2011cites this paper
• Molecular and species-specific determinants of aryl hydrocarbon receptor transcriptional activity

  2010cites this paper
• Selected Pneumotoxic Agents

  2010cites this paper
• Metabolism and interactions of pesticides in human and animal in vitro hepatic models

  2010cites this paper
• Ontogeny of hepatic drug metabolizing enzymes in sheep

  2010cites this paper
• Caenorhabditis elegans generates biologically relevant levels of genotoxic metabolites from aflatoxin B1 but not benzo[a]pyrene in vivo.

  2010cites this paper
• Characterization of a new cytochrome P450 enzyme, CYP2S1, in rats: its regulation by aryl hydrocarbon receptor agonists.

  2010cites this paper
• Profiling gene expression of whole cytochrome P450 superfamily in human bronchial and peripheral lung tissues: Differential expression in non-small cell lung cancers.

  2010cites this paper
• Role of cytochromes P450 and peroxidases in metabolism of the anticancer drug ellipticine: additional evidence of their contribution to ellipticine activation in rat liver, lung and kidney.

  2010cites this paper
• Drug-induced and Iatrogenic Respiratory Disease

  2010cites this paper
• Characterization and expression of extrahepatic CYP2S1

  2009cites this paper
• QSAR of cytochrome inhibitors

  2009cites this paper
• Cytochrome P450-mediated metabolism in the human gut wall.

  2009cites this paper
• Fatty Acid Hydroperoxides Support Cytochrome P450 2S1-Mediated Bioactivation of Benzo[a]pyrene-7,8-dihydrodiol

  2009cites this paper
• Effect of beta-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig.

  2009cites this paper
• FUNCTIONAL CHARACTERIZATION OF HUMAN CYTOCHROME P450 2S1 USING A SYNTHETIC GENE-EXPRESSED PROTEIN IN E. coli

  2009cites this paper
• OF HUMAN CYTOCHROME P 450 2 S 1 USING A SYNTHETIC GENE-EXPRESSED PROTEIN IN E . coli

  2009cites this paper
• Functional Characterization of Human Cytochrome P450 2S1 Using a Synthetic Gene-Expressed Protein in Escherichia coli

  2009cites this paper
• Cytochrome P450‐mediated metabolism in the human gut wall

  2009cites this paper
• DETAILED REVIEW PAPER ON THE USE OF METABOLISING SYSTEMS FOR IN VITRO TESTING OF ENDOCRINE DISRUPTORS Environment Directorate ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT

  2008cites this paper
• The use of metabolising systems for in vitro testing of endocrine disruptors.

  2008cites this paper
• Epigenic regulation and posttranslational modification of human cytochrome P450s : Focus on CYP2W1, CYP1A2 and CYP2C18

  2008cites this paper
• EPIGENETIC REGULATION AND POSTTRANSLATIONAL MODIFICATION OF HUMAN CYTOCHROME P 450 s : FOCUS ON CYP 2 W 1 , CYP 1 A 2 AND CYP 2 C 18

  2008cites this paper
• Isolation and Functional Characterization of a Dioxin-Inducible CYP1A Regulatory Region From Zebrafish ( Danio rerio )

  2008cites this paper